July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Inhibition of pterygium fibroblasts viability by a Siempre viva plant extract partitioned in Aqueous-Two Phase Systems
Author Affiliations & Notes
  • Daniela Enriquez-Ochoa
    ITESM, Mexico
  • Calef Sánchez-Trasviña
    ITESM, Mexico
  • Karla Mayolo-Deloisa
    ITESM, Mexico
  • Paloma Lopez
    ITESM, Mexico
  • Judith Zavala
    ITESM, Mexico
  • Marco Rito-Palomares
    ITESM, Mexico
  • Jorge E. Valdez-García
    ITESM, Mexico
  • Footnotes
    Commercial Relationships   Daniela Enriquez-Ochoa, None; Calef Sánchez-Trasviña, None; Karla Mayolo-Deloisa, None; Paloma Lopez, None; Judith Zavala, None; Marco Rito-Palomares, None; Jorge E. Valdez-García, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3425. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Daniela Enriquez-Ochoa, Calef Sánchez-Trasviña, Karla Mayolo-Deloisa, Paloma Lopez, Judith Zavala, Marco Rito-Palomares, Jorge E. Valdez-García; Inhibition of pterygium fibroblasts viability by a Siempre viva plant extract partitioned in Aqueous-Two Phase Systems. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3425.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The only available treatment for pterygium is surgical removal, which produces high recurrence rates. Pharmaceutical approaches focus in post-surgical treatment to avoid recurrence. Siempre viva is an endemic Mexican plant with healing and anti-inflammatory properties. We partitioned Siempre viva plant extract in ethanol-salt Aqueous-Two Phase Systems (ATPS) in order to characterize its composition and test viability inhibition over pterygium fibroblasts.

Methods : Lyophilized Siempre viva extracts was obtained from leaves and stems. All ATPS were constructed with ethanol and potassium buffer phosphate (K2HPO4–KH2PO4) , and a total weight of 2 g with 10% w/w of sample. Each ATPS was loaded with 1 mg of the extract. The effect of the tie line length (TLL) on the extract partition was evaluated (TLL 40, 50, 60 and 70). Each phase was collected for determination of total phenolics concentration, total protein and antioxidant capacity by Folin-Ciocalteu method, Bradford technique and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonate) (ABTS) assay. Pterygium fibroblasts obtained from human surgically removed samples were cultivated with DMEM-F12 medium. Cell viability inhibition was determined using Cell Titer at 24h post-treatment with the top phase of the ATPS.

Results : The highest percentage of total phenolics was recovered in the top phase (67.8%) of the alcohol-salt ATPS at TLL of 70. The highest recovery percentage of total protein in the top phase was obtained at TLL of 60 (60%) and the lowest percentage was obtained at a TLL of 70 (19.6%). For the antioxidant activity, at TLL of 40 the highest activity was determined in the top phase, whereas the lowest was obtained at TLL of 60. The highest inhibition of cell viability was observed with the top phase at TLL of 50 (25%), while the lowest percentage of inhibition was observed with the top phase at TLL of 60 (105%).

Conclusions : The compounds obtained through partition of the Siempre viva plant extract with ATPS inhibited cell viability in pterygium fibroblasts. Further analysis of their biological effect will provide more information about the potential use of the Siempre viva plant extract as a therapeutic approach for pterygium treatment.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×